DK2525782T3 - Formuleringer af nanobærere og fremgangsmåder til fremstilling deraf - Google Patents
Formuleringer af nanobærere og fremgangsmåder til fremstilling deraf Download PDFInfo
- Publication number
- DK2525782T3 DK2525782T3 DK11732743.7T DK11732743T DK2525782T3 DK 2525782 T3 DK2525782 T3 DK 2525782T3 DK 11732743 T DK11732743 T DK 11732743T DK 2525782 T3 DK2525782 T3 DK 2525782T3
- Authority
- DK
- Denmark
- Prior art keywords
- nanotubes
- formulations
- making
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/624—Nanocapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
- A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Optics & Photonics (AREA)
- Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN133MU2010 | 2010-01-18 | ||
PCT/IN2011/000006 WO2011086574A2 (en) | 2010-01-18 | 2011-01-06 | Formulations of nano-carriers and methods of preparing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2525782T3 true DK2525782T3 (da) | 2019-06-11 |
Family
ID=44304741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK11732743.7T DK2525782T3 (da) | 2010-01-18 | 2011-01-06 | Formuleringer af nanobærere og fremgangsmåder til fremstilling deraf |
Country Status (9)
Country | Link |
---|---|
US (1) | US20120321670A1 (da) |
EP (1) | EP2525782B1 (da) |
CA (1) | CA2786671A1 (da) |
DK (1) | DK2525782T3 (da) |
ES (1) | ES2726952T3 (da) |
PL (1) | PL2525782T3 (da) |
PT (1) | PT2525782T (da) |
TR (1) | TR201906372T4 (da) |
WO (1) | WO2011086574A2 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL3057604T3 (pl) | 2013-10-14 | 2021-12-20 | Nanosphere Health Sciences Inc. | Kompozycje nanocząstek i sposoby jako nośniki czynników nutraceutycznych przez błony komórkowe i bariery biologiczne |
WO2016044482A1 (en) * | 2014-09-17 | 2016-03-24 | Vivacelle Bio, Inc. | Stable micelle and/or liposome compositions and uses thereof |
CA2970917C (en) | 2014-12-15 | 2019-09-17 | Nanosphere Health Sciences, Llc | Methods of treating inflammatory disorders and global inflammation with compositions comprising phospholipid nanoparticle encapsulations of nsaids |
CN104586817A (zh) * | 2015-02-11 | 2015-05-06 | 苏州大学 | 一种多西他赛固体脂质纳米粒冻干制剂及其制备方法 |
CA3089686A1 (en) | 2015-03-10 | 2016-09-15 | Nanosphere Health Sciences, Llc | A nanoparticle drug delivery comprising liquid lipids and cannabinoids encapsulated in a single layer of essential phospholipids |
BR112021011087A2 (pt) | 2018-12-11 | 2021-08-31 | Disruption Labs Inc. | Composições para a entrega de agentes terapêuticos e métodos de uso e fabrico dos mesmos |
AU2021242202B2 (en) | 2020-03-27 | 2024-01-11 | Boston Scientific Scimed, Inc. | Methods for crystallization of drugs |
CN111671982A (zh) * | 2020-05-08 | 2020-09-18 | 北京永益润成科技有限公司 | 一种药物涂层组合物及其制备方法 |
CN114886855B (zh) * | 2022-05-19 | 2023-10-03 | 北京柏欧利诺生物科技有限公司 | 一种雷公藤红素纳米药物及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040208877A1 (en) * | 2002-07-01 | 2004-10-21 | Avigdor Levanon | Antibodies and uses thereof |
CA2505520C (en) * | 2002-11-06 | 2012-07-17 | Azaya Therapeutics, Inc. | Protein-stabilized liposomal formulations of pharmaceutical agents |
WO2004069169A2 (en) | 2003-01-31 | 2004-08-19 | Scimed Life Systems, Inc. | Localized drug delivery using drug-loaded nanocapsules and implantable device coated with the same |
CN1493361A (zh) * | 2003-08-29 | 2004-05-05 | 上海医药工业研究院 | 山榆酸甘油酯的脂质纳米粒及其制备方法 |
JP2007526322A (ja) * | 2004-03-02 | 2007-09-13 | マサチューセッツ インスティテュート オブ テクノロジー | ナノセル薬物送達系 |
BRPI0600275A (pt) * | 2006-01-03 | 2007-10-02 | Brz Biotecnologia Ltda | prótese coronária liberadora de composição medicamentosa para prevenção e tratamento da reestenose e processo de fabricação |
US20090110739A1 (en) * | 2007-05-15 | 2009-04-30 | University Of North Texas Health Science Center At Forth Worth | Targeted cancer chemotherapy using synthetic nanoparticles |
DE102007061624A1 (de) * | 2007-05-31 | 2009-06-25 | Ernst-Moritz-Arndt-Universität Greifswald | Verfahren zur Beschichtung von Oberflächen mit Mikro- und Nanopartikeln mit Hilfe von Plasmaverfahren und dessen Verwendung |
CN101167699A (zh) * | 2007-11-28 | 2008-04-30 | 厦门大学 | 胰岛素口服缓释制剂及其制备方法 |
US8343497B2 (en) * | 2008-10-12 | 2013-01-01 | The Brigham And Women's Hospital, Inc. | Targeting of antigen presenting cells with immunonanotherapeutics |
DK2434994T3 (da) * | 2009-05-29 | 2018-10-08 | Envision Scient Private Limited | Genoprettelse af blodgennemstrømning i blokerede menneskearterier ved overførsel af nanoindkapslet lægemiddel igennem medicinske indretninger udformet dertil og frigørelse af det nanoindkapslede lægemiddel i menneskearterier med krops-pH-værdi |
DK2437844T3 (da) * | 2009-06-02 | 2018-07-30 | Concept Medical Inc | Foryngelse af koronararterien ved forbedring af blodgennemstrømningen ved hjælp af indføring af nanobolde (indkapslede nanopartikler) indeholdende terapeutiske midler med en ikke-implanterbar indretning til væv og derved tilvejebringelse af frigivelse i vævet rettet mod den krævede cellecyklus |
-
2011
- 2011-01-06 PL PL11732743T patent/PL2525782T3/pl unknown
- 2011-01-06 US US13/063,198 patent/US20120321670A1/en not_active Abandoned
- 2011-01-06 ES ES11732743T patent/ES2726952T3/es active Active
- 2011-01-06 CA CA2786671A patent/CA2786671A1/en not_active Abandoned
- 2011-01-06 PT PT11732743T patent/PT2525782T/pt unknown
- 2011-01-06 WO PCT/IN2011/000006 patent/WO2011086574A2/en active Application Filing
- 2011-01-06 EP EP11732743.7A patent/EP2525782B1/en active Active
- 2011-01-06 DK DK11732743.7T patent/DK2525782T3/da active
- 2011-01-06 TR TR2019/06372T patent/TR201906372T4/tr unknown
Also Published As
Publication number | Publication date |
---|---|
TR201906372T4 (tr) | 2019-05-21 |
US20120321670A1 (en) | 2012-12-20 |
EP2525782A4 (en) | 2014-05-28 |
PL2525782T3 (pl) | 2019-09-30 |
EP2525782A2 (en) | 2012-11-28 |
CA2786671A1 (en) | 2011-07-21 |
ES2726952T3 (es) | 2019-10-10 |
EP2525782B1 (en) | 2019-03-13 |
PT2525782T (pt) | 2019-06-06 |
WO2011086574A2 (en) | 2011-07-21 |
WO2011086574A3 (en) | 2011-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2929031T5 (da) | Pcsk9-irna-sammensætninger og fremgangsmåder til anvendelse deraf | |
DK2648742T3 (da) | Formuleringer indeholdende saponiner og anvendelser deraf | |
DK2872153T3 (da) | Accellulære pro-tolerogene sammensætninger og fremgangsmåde til fremstilling heraf | |
DK3795573T3 (da) | Bestemte triazolopyraziner, sammensætninger deraf og fremgangsmåder til anvendelse deraf | |
DK2648809T3 (da) | Naturlige formuleringer | |
DK2525782T3 (da) | Formuleringer af nanobærere og fremgangsmåder til fremstilling deraf | |
DK2739293T3 (da) | Fremgangsmåder og sammensætninger til frembringelse af vaccinavirus | |
DK3202460T3 (da) | Arylmethoxy-isoindolinderivater og sammensætninger omfattende og fremgangsmåder til anvendelser af samme | |
DK2694091T3 (da) | Fremgangsmåde til fremstilling af kompakte tale-nukleaser og anvendelse heraf | |
DK2593463T3 (da) | Formuleringer af rifaximin og anvendelser deraf | |
DK3213738T3 (da) | Sammensætninger og fremgangsmåder til målrettet termomodulering | |
DK2691443T3 (da) | Konjugerede lipomerer og anvendelser af disse | |
DK3252057T3 (da) | Multicykliske forbindelser og fremgangsmåder til anvendelse deraf | |
DK2602089T3 (da) | Resinform til nanotryk og fremgangsmåde til fremstilling deraf | |
DK3339323T3 (da) | Anti-n3pglu-amyloid-beta-peptid-antistoffer og anvendelser deraf | |
DK3662932T3 (da) | Anti-cgrp-sammensætninger og anvendelse deraf | |
DK2675827T3 (da) | Hidtil ukendte modulatorer og fremgangsmåder til anvendelse | |
DK2521221T4 (da) | Høreanordning og fremgangsmåde | |
DK2498756T3 (da) | Tabletformuleringer af neratinibmaleat | |
DK2892912T3 (da) | C17-alkandiyl og alkenediylderivater af oleanolsyre og fremgangsmåder til anvendelse deraf | |
DK2663864T3 (da) | Fremgangsmåde til at vurdere immundiversitet og anvendelse af denne | |
DK2600715T3 (da) | Flydende ST-246-formuleringer og fremgangsmåder | |
DK2533761T3 (da) | Fremgangsmåder og sammensætninger til fremstilling af aerosoler | |
DK2647068T3 (da) | Batterielektrode og metode til fremstilling af samme | |
DK3831406T3 (da) | Stabile formuleringer af Neisseria-Meningitidis-RLP2086-antigener |